NEMO Syndrome (Incontinentia Pigmenti) and Systemic Lupus Erythematosus: A New Disease Association
January 2012
in “
Lupus
”
Studysummary This case report is the first to associate NEMO syndrome with systemic lupus erythematosus, suggesting a potential role for NF-kB essential modulator in the pathogenesis of SLE.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
This document reported the first known association between NEMO syndrome (incontinentia pigmenti) and systemic lupus erythematosus (SLE) in a 35-year-old pregnant patient. The patient, diagnosed with SLE at age 24, exhibited multisystemic symptoms and had a family history of related anomalies. Genetic testing confirmed NEMO syndrome, characterized by developmental anomalies and immunodepression. The findings suggested that the NF-kB essential modulator gene, implicated in immune deficiencies, might play a role in the pathogenesis of SLE, highlighting the complex interplay between congenital and autoimmune diseases.